Top Stories
All Sections
Finance
About
17 results for "discovery"
Fanatics deployed an OpenAI-powered AI recommendation engine that matches fan preferences to merchandise across 1.5 million SKUs — moving sports retail discovery from search to conversation.
Four federal courts issued AI protective orders in four days, naming specific AI platforms and restricting their use with confidential discovery materials — marking a shift from novelty to standard of care in commercial litigation.
Isomorphic Labs, the AI drug discovery company spun out of Google DeepMind, is in talks to raise at a valuation of $40–50 billion — just five months after closing a $2.1 billion Series B.
Anthropic's AI-powered Project Glasswing uncovered 129,000 verified software vulnerabilities in four months, including 33,000 critical or high severity, and is now expanding into a tiered external access program.
Meta AI's Muse Spark models collaborated with human mathematicians to co-author six peer-reviewed papers, five of which solve previously open mathematics problems — among the most concrete demonstrations yet of AI contributing to original scientific discovery.
Anthropic launched a dedicated life sciences research group and released its first finding: Claude autonomously identified a previously unknown bacteriophage enzyme system with structural similarities to CRISPR arrays.
Google DeepMind released a free public database of precomputed predictions for all 9 billion possible human DNA mutations — potentially compressing rare disease diagnosis from months to hours.
Novo Nordisk is embedding OpenAI across every stage of drug development—from discovery to manufacturing and sales—targeting full integration by end of 2026.
Anthropic has publicly released Claude Fable — the renamed Claude Mythos — opening enterprise access to a security AI that autonomously found more than 10,000 high or critical vulnerabilities during its restricted preview.
Amazon's AI shopping assistant Rufus has crossed 250 million users — and sellers who haven't adapted for AI-powered discovery face a structural disadvantage heading into Prime Day 2026.
A 2026 NVIDIA survey finds AI deployments generating measurable returns across radiology, pathology, and drug discovery as clinical adoption crosses from pilots into sustained enterprise deployment.
OpenAI cut genomics compute costs 31% with a GPT-Rosalind update and opened global research access — while launching a sponsored Biodefense program for vetted public-health and government partners.
Google unveiled Gemini for Science at I/O 2026, giving researchers natural-language access to model biological, chemical, and physical systems using AlphaFold and Google Scholar integration.
Palo Alto Networks' May patch cycle found 26 CVEs using frontier AI models — versus the typical fewer than 5 per month. The window between vulnerability disclosure and weaponized exploit is shrinking fast.
A federal magistrate judge in Michigan ruled that a litigant's ChatGPT conversations cannot be compelled by opposing counsel — the first ruling to extend work product protection to AI chat logs.
A new NVIDIA-commissioned survey finds AI is producing measurable returns across healthcare, with hospitals reporting concrete gains in radiology throughput, diagnostic accuracy, and drug discovery timelines.
Merck and Google Cloud announced a partnership worth up to $1 billion to deploy Gemini-powered AI agents across drug discovery, manufacturing, and commercial operations — one of the largest pharma-AI deals on record.